The ERK pathway plays a critical role in embryonic development and tissue repair because it instructs cells to multiply and start dividing, but when over activated cancer growth occurs.
While investigating a potential therapeutic target for the ERK1 and 2 pathway, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, University of California San Diego School of Medicine researchers found that an alternative pathway immediately emerges when ERK1/2 is halted, thus allowing tumor cell proliferation to continue.
In a paper published in the journal Nature Communications, researchers report that treating both ERK1/2 and the compensatory pathway, ERK5, concurrently with a combination of drug inhibitors halted colorectal cancer growth more effectively in both mouse models and human colorectal cancer cell lines.
Researchers show that loss of Erk1/2in intestinal epithelial cells results in defects in nutrient absorption, epithelial cell migration and secretory cell differentiation. However, intestinal epithelial cell proliferation is not impeded, implying compensatory mechanisms.
Genetic deletion of Erk1/2 or pharmacological targeting of MEK1/2 results in supraphysiological activity of the ERK5 pathway. Furthermore, targeting both pathways causes a more effective suppression of cell proliferation in murine intestinal organoids and human CRC lines.
"Therapies aimed at targeting ERK1/2 likely fail because this mechanism is allowing proliferation through a different pathway," said senior author. "Previously, ERK5 didn't seem important in colorectal cancer. This is an underappreciated escape pathway for tumor cells. Hence, the combination of ERK1/2 and ERK5 inhibitors may lead to more effective treatments for colorectal cancer patients."
http://www.eurekalert.org/pub_releases/2016-05/uoc--bkc051716.php
Latest News
A signaling molecule that potently stimulates hair growth
New pathway for accumulation of age-promoting 'zombie cells'
Protecting the brain from dementia-inducing abnormal protein aggregates
Why many cancer cells need to import fat
Role of nonsense-mediated mRNA decay (NMD) in fragile X-syndrome
Other Top Stories
Faster genome analysis using smart phone!
Combined visual and auditory treatment ameliorates Alzheimer's-associated pathology and improves cognition
Single neuron anatomy of the brain!
A brain-computer interface (BCI) based neurofeedback to modify an individual's arousal state
Predicting cognitive development at age 2 using AI and MRI
Protocols
Light and electron microscopic imaging of synaptic vesicle endocytosis at mouse hippocampal cultures
FLAMBE: A kinetic fluorescence polarization assay to study activation of monomeric BAX
Single-cell mass spectrometry
A behavioral paradigm for measuring perceptual distances in mice
Rapid detection of an Ebola biomarker with optical microring resonators
Publications
Cough hypersensitivity and chronic cough
Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening
The why and how of adaptive immune responses in ischemic cardiovascular disease
Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's d…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER